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Abstract	  Eyeblink	   conditioning	   (EBC)	   is	   an	   important	  procedure	  used	   to	  understand	   the	  neuronal	  plasticity	   that	   occurs	   with	   learning	   and	   memory.	   Delay	   EBC	   requires	   a	   brainstem-­‐cerebellar	  circuit	  while	   the	  role	  of	   the	  cerebellum	   in	   trace	  EBC	   is	  not	  as	  well	  understood	  because	   it	   requires	   a	   more	   complex	   neural	   circuitry	   involving	   regions	   of	   the	   medial	  prefrontal	   cortex	   and	   hippocampus.	   Secretin	   is	   a	   neuropeptide	   that	   is	   found	   in	   high	  concentrations	  within	   the	   cerebellum.	   Previous	  work	   has	   shown	   that	   blocking	   secretin’s	  effects	   in	   the	   cerebellum	   with	   intra-­‐cerebellar	   infusion	   of	   relatively	   large	   volume	   of	   a	  secretin	  receptor	  antagonist	  impairs	  delay	  EBC	  (Fuchs	  et	  al.	  2014).	  Here	  we	  study	  the	  effect	  that	   intra-­‐cerebellar	   infusion	   of	   0.5	   μL	   secretin	   receptor	   antagonist	   (5-­‐27	   secretin)	   or	  vehicle	  prior	  to	  training	  sessions	  1	  and	  2	  has	  on	  delay	  and	  trace	  EBC	  in	  rats.	  A	  600-­‐ms	  tone	  CS	  was	  used	  for	  the	  delay	  EBC	  paradigm	  and	  a	  300-­‐ms	  tone	  CS	  followed	  by	  a	  300-­‐ms	  trace	  interval	   was	   used	   for	   the	   trace	   EBC	   paradigm.	   For	   delay	   EBC,	   the	   delay	   vehicle	   and	  antagonist	  groups	  displayed	  similar	  acquisition	  of	  conditioned	  responses	  (CRs).	  There	  was	  a	   trend	   for	   the	   trace	   antagonist	   group	   to	   underperform	   compared	   to	   the	   trace	   vehicle	  group	   though	  not	  quite	  at	   a	   significant	   level.	  One	  explanation	   for	  why	   the	   results	   for	   the	  delay	  EBC	  do	  not	  support	  previous	  work	  is	  that	  slow	  learning	  occurred	  in	  the	  delay	  vehicle	  group	   that	  may	  have	  prevented	   the	  effects	  of	   secretin	   receptor	  antagonist	   from	  reaching	  significance.	  The	   trend	   for	   the	   trace	  antagonist	   group	   to	  display	  decreased	  acquisition	  of	  CRs	   suggests	   that	   the	   cerebellum	  does	   play	   an	   important	   role	   in	   trace	   EBC.	  However,	   in	  order	  to	  better	  understand	  the	  neural	  circuitry	  involved	  in	  trace	  EBC,	  future	  work	  should	  analyze	  the	  role	  that	  cerebellar	  secretin	  itself	  has	  on	  trace	  EBC.	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Introduction	  	  Eyeblink	  conditioning	  (EBC)	   is	  a	   form	  of	  classical	  conditioning	  that	  can	  be	  used	  to	  study	   the	   neural	   mechanisms	   involved	   in	   learning	   and	   memory.	   EBC	   occurs	   when	   a	  conditioned	   stimulus	   (CS)	   such	   as	   a	   tone	   or	   the	   flashing	   of	   a	   light	   precedes	   an	  unconditioned	  stimulus	  (US)	  such	  as	  an	  electrical	  shock	  to	  the	  periorbital	  region	  of	  the	  eye.	  	  The	  US	  causes	  the	  animal	  to	  reflexively	  blink	  its	  eye.	  	  This	  response	  to	  the	  US	  is	  known	  as	  the	  unconditioned	  response	  (UR).	  	  When	  the	  animal	  undergoes	  many	  pairings	  of	  the	  CS	  and	  US,	  it	  learns	  to	  blink	  when	  the	  CS	  is	  presented,	  in	  anticipation	  of	  the	  US.	  	  This	  response	  to	  the	  CS	   is	  called	   the	  conditioned	  response	  (CR).	   	  The	  acquisition	  of	   the	  CR	  when	  the	  CS	   is	  presented	  is	  considered	  a	  learned	  response.	  EBC	  can	  be	  divided	  into	  delay	  conditioning	  and	  trace	   conditioning.	   Delay	   EBC	   is	   when	   the	   CS	   and	   US	   overlap	   each	   other	   with	   the	   CS	  beginning	  slightly	  (usually	  about	  half	  a	  second)	  before	  the	  US.	   	  Trace	  EBC	  is	  when	  the	  CS	  and	  US	  do	  not	  overlap	  with	  the	  CS	  occurring	  first,	  followed	  by	  a	  short	  period	  (usually	  about	  half	  a	  second)	  with	  no	  stimuli,	  and	  then	  the	  US.	  Delay	  EBC	  has	  been	  found	  to	  be	  dependent	  on	   one	   of	   the	   deep	   cerebellar	   nuclei	   (the	   interpositus	   nucleus)	   and	   the	   region	   of	   the	  cerebellar	   cortex	   that	   is	   ipsilateral	   to	   the	   eye	   that	   is	   receiving	   the	   US	   (as	   reviewed	   by	  Freeman	  and	  Steinmetz,	  2011).	  On	  the	  other	  hand,	  the	  role	  of	  the	  cerebellum	  in	  trace	  EBC	  is	   still	   debated	   (Woodruff-­‐Pak	   &	   Disterhoft,	   2008)	   given	   that	   it	   also	   requires	   forebrain	  brain	   regions	   (Kalmbach	   et	   al.	   2009;	  Kalmbach	  et	  al.	  2010;	  Siegel	  et	  al.	  2015).	  	  The	   cerebellar	   cortex	   is	   composed	  of	  three	   layers:	   granule	   layer,	   Purkinje	   cell	  layer,	  and	  molecular	   layer.	  The	  Purkinje	  cell	  layer	   is	   located	   between	   the	   granule	   and	  molecular	   layers	   (Figure	   1).	   Purkinje	   cells	  (PC)	   provide	   the	   sole	   output	   from	   the	  cerebellar	  cortex.	  These	  cells	  are	  GABAergic	  and	   most	   PC	   axons	   terminate	   in	   the	   deep	  cerebellar	  nuclei	  (DCN)	  located	  in	  the	  center	  of	   the	   cerebellum.	   The	   rodent	   DCN	   is	  composed	   of	   three	   nuclei:	   dentate,	  
Figure	   1.	   Cell	   layers	   of	   cerebellar	   cortex,	  inputs	   (mossy	   fibers,	   climbing	   fibers)	   and	  outputs	  (Purkinje	  cell	  axons).	  	  Adapted	  from	  Purves	  et	  al.	  (2012).	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interpositus	  and	  fastigial.	  Located	  in	  the	  granule	  layer,	  granule	   cells	   are	   a	   type	  of	   glutamatergic	   interneuron	  that	  receive	  input	  from	  other	  brain	  regions	  via	  mossy	  fibers	   (Figure	   2).	   Basket	   cells	   (BC)	   are	   a	   type	   of	  GABAergic	   neuron	   in	   the	   molecular	   layer	   that	  synapses	   on	   axons	   of	   PCs	   providing	   feed	   forward	  inhibition	   of	   these	   cells	   When	   granule	   cells	   become	  activated	  by	  mossy	  fibers,	  they	  excite	  BCs	  (not	  shown)	  allowing	  for	  BCs	  to	  inhibit	  PCs	  (as	  reviewed	  by	  Voogd	  and	  Glickstein,	  1998).	  	  	  
Neural	  Substrates	  of	  Delay	  Eyeblink	  Conditioning	  	   Delay	   EBC	   utilizes	   a	   specific	   neural	   circuit	   in	  the	   cerebellum	   and	   brain	   stem	   (Figure	   3).	   	   Mossy	  fibers	   originating	   in	   the	   pontine	   nuclei	   deliver	   the	  auditory	  CS	  to	  granule	  cells,	  which	  then	  relay	  it	  to	  PCs	  (and	  BCs)	  via	  parallel	  fibers.	  Mossy	  fibers	  also	  project	  to	  the	  IPN	  located	  in	  the	  DCN.	  Neurons	  in	  the	  IPN	  project	  to	  the	  red	  nucleus	  located	  in	  the	  midbrain.	   Activation	   of	   the	   red	   nucleus	   by	   the	   IPN	   is	   what	   allows	   for	   a	   learned	   motor	  response	  to	  occur	  during	  EBC	  (as	  reviewed	  by	  Christian	  and	  Thompson,	  2003).	  	  The	  US	  is	  relayed	  to	  Purkinje	  cells	  via	  climbing	  fibers	  originating	  from	  the	  inferior	  olive	  (as	  reviewed	  by	  Freeman	  and	  Steinmetz,	  2011).	  Usually,	  PCs	  tonically	  inhibit	  neurons	  in	  the	  IPN	  of	  the	  DCN.	  The	  plasticity	  that	  occurs	  in	  PCs	  and	  in	  the	  IPN	  is	  what	  allows	  for	  the	  acquisition	  of	  CRs	  (Garcia	  and	  Mauk,	  1998;	  Rasmussen	  et	  al,	  2014).	  Garcia	  and	  Mauk	  (1998)	  found	  that	  infusion	   of	   muscimol,	   a	   GABA	   receptor	   agonist,	   into	   the	   IPN	   of	   albino	   rabbits	   prior	   to	  training	  completely	  abolished	  CRs	  in	  delay	  EBC.	  In	  the	  same	  study,	  infusion	  of	  picrotoxin,	  a	  GABA	  receptor	  antagonist,	   into	   the	   IPN	  after	  EBC	   training	  altered	   the	   response	   timing	  of	  CR.	  Picrotoxin	  would	  prevent	  GABA	  released	   from	  PCs	   from	  binding	  onto	  neurons	   in	   the	  IPN.	  These	  findings	  suggest	  that	  the	  CS	  can	  induce	  neural	  activity	  in	  trained	  animals	  via	  the	  increased	  synaptic	  activity	  between	  mossy	  fibers	  and	  the	  IPN.	  Furthermore,	  the	  disruption	  of	   CR	   timing	   with	   picrotoxin	   infusions	   supports	   the	   idea	   that	   the	   cerebellar	   cortex	   in	  
Figure	   2.	   Circuitry	   of	   cerebellar	  cortex	   and	   the	   deep	   cerebellar	  nuclei.	   	   Adapted	   from	   Purves	   et	  al.	  (2012).	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trained	  animals	  provides	  temporal	  coding	   signals	   in	   the	   form	   of	  decreased	   PC	   activity	   to	   the	   IPN	  that	   allow	   for	   the	   coordinated	  execution	   of	   CRs.	   Ablation	   lesions	  of	   the	   cerebellar	   cortex	   by	   Garcia	  et	   al	   (1999)	   prior	   to	   training	  produced	   a	   decrease	   in	  acquisition.	  	  	  
Neural	   Substrates	   of	   Trace	  
Eyeblink	  Conditioning	  Some	   studies	   have	  suggested	  that	  the	  neural	  circuitry	  in	   the	  cerebellum	   for	   trace	  EBC	   is	  similar	   to	   the	   cerebellar	   circuitry	  for	   delay	   EBC	   (Takehara	   et	   al.	  2003;	   Woodruff-­‐Pak	   and	   Disterhoft	   2008).	   For	   example,	   Woodruff-­‐Pak	   et	   al.	   (1985)	  conducted	  an	  experiment	   in	  which	   the	   ipsilateral	   IPN	  was	   lesioned	   in	  albino	  rabbits	   that	  then	   underwent	   trace	   EBC.	   The	   CRs	   were	   fully	   prevented	   in	   animals	   with	   IPN	   lesions	  suggesting	   that	   acquisition	   in	   trace	   EBC	   also	   requires	   the	   IPN.	   Siegel	   et	   al.	   (2015)	   first	  trained	   mice	   to	   asymptotic	   performance	   and	   then	   infused	   muscimol	   into	   the	   IPN	   15-­‐minutes	  prior	  to	  the	  next	  training	  session	  and	  found	  that	  CRs	  were	  abolished.	  The	  findings	  of	   this	   study	   suggest	   that	   the	   expression	   of	   trace	   eyeblink	   CRs	   is	   cerebellar	   dependent.	  	  Finally,	  IPN	  single-­‐unit	  activity	  is	  similar	  in	  delay	  and	  trace	  EBC	  (Green	  &	  Arenos,	  2007).	  However,	  the	  role	  of	  the	  cerebellum	  in	  trace	  EBC	  is	  still	  a	  controversial	  topic.	  Some	  studies	  have	   found	   that	   removal	  of	  PCs	  does	  not	  affect	  acquisition	  of	   trace	  EBC	  but	  does	  slow	  acquisition	  of	  delay	  EBC	  (Brown	  et	  al.,	  2009,	  Woodruff-­‐Pak	  et	  al.	  2006).	  Brown	  et	  al	  (2009)	  used	  4-­‐5	  month	  old,	  homozygous	  pcd	  mutant	  mice	  and	  wildtype	  mice	  of	  the	  same	  age	  to	  study	  the	  role	  of	  the	  cerebellum	  in	  trace	  EBC.	  The	  pcd	  mutant	  mice	  lose	  all	  of	  their	  PCs	  by	  the	  fourth	  week	  of	  age.	  It	  was	  found	  that	  the	  pcd	  mutant	  group	  did	  not	  differ	  from	  
Figure	   3.	   Simplified	   cerebellar	   learning	   circuit.	  Information	   about	   the	   CS	   enters	   the	   cerebellum	   from	  the	   pontine	   nuclei	   while	   information	   about	   the	   US	  enters	   from	   the	   inferior	   olive.	   The	   cerebellar	   cortex	  contains	  PCs	  that	  tonically	   inhibit	  the	  IPN.	  The	  removal	  of	  this	  inhibition	  allows	  the	  IPN	  to	  signal	  the	  red	  nucleus	  in	   the	  midbrain	   to	  produce	   a	   conditioned	  eye	   blink	  via	  the	   facial	   nucleus.	   From	   Christian	   and	   Thompson	  (2003).	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the	   wildtype	   group	   in	   CR	   frequency	   or	   CR	   amplitude.	   	   These	   findings	   suggest	   that	   the	  cerebellar	  cortex	  is	  not	  necessary	  for	  trace	  EBC.	  Woodruff-­‐Pak	  et	  al	  (2006)	  used	  Purkinje	  Scn8a	   knockout	  mice	   and	  wildtype	  mice	   and	   trained	   them	   either	  with	   a	   delay	   paradigm	  consisting	  of	   trials	   in	  which	   a	  600-­‐ms	   tone	  CS	   co-­‐terminated	  with	   a	  100-­‐ms	  US	   stimulus	  (500-­‐ms	  delay)	  or	  with	  a	  trace	  paradigm	  consisting	  of	  a	  250-­‐ms	  CS	  tone	  followed	  by	  a	  250-­‐ms	  trace	  interval	  followed	  by	  a	  100-­‐ms	  US	  stimulation.	  The	  Scn8a	  gene	  codes	  for	  a	  sodium	  channel	  subunit	   that	  when	  removed	  causes	  a	  decrease	   in	   firing	  rate	  of	  PCs.	  The	  Purkinje	  Scn8a	   knockout	   displayed	   an	   impairment	   of	   acquisition	   in	   delay	   EBC	   but	   not	   trace	   EBC	  compared	  to	  the	  control	  group.	  	  	  	   Other	   studies	   have	   found	   that	   trace	   EBC	   requires	   interaction	   between	   the	  hippocampus	   and	   cerebellum	   (Solomon	   et	   al.1986;	  Weiss	   et	   al.	   1999;	   Tseng	   et	   al.	   2004)	  and	   regions	   of	   the	  medial	   prefrontal	   cortex	   (mPFC)	   and	   the	   cerebellum	   (Kalmbach	   et	   al.	  2009;	  Kalmbach	  et	  al.	  2010;	  Siegel	  et	  al.	  2015;	  Takehara	  et	  al.	  2005;	  Siegel	  and	  Mauk,	  2013;	  Siegel	   et	   al.	   2015).	   Bilateral	   aspiration	   lesions	   to	   the	   hippocampi	   of	   three	  month	   old	   F1	  hybrid	  rats	  significantly	  impaired	  CR	  frequency	  and	  CR	  amplitude	  in	  trace	  EBC	  compared	  to	  the	  control	  group	  that	  did	  not	  receive	  the	  lesions	  (Weiss	  et	  al.	  1999).	  In	  the	  experiment	  conducted	   by	   Siegel	   et	   al	   (2015)	   with	   mice,	   bilateral	   aspiration	   lesions	   to	   the	   caudal	  regions	   (between	   bregma	   +1.75	   and	   +0.75)	   of	   the	   mPFC	   prior	   to	   training	   prevented	  acquisition	  of	  CRs	  in	  EBC	  with	  250-­‐ms	  trace	  intervals.	  This	  evidence	  supports	  the	  view	  that	  trace	  EBC	  requires	  specific	  forebrain	  regions	  in	  addition	  to	  the	  cerebellum	  for	  acquisition	  to	   occur.	   Due	   to	   the	   stimulus-­‐free	   period	   between	   the	   CS	   and	   the	  US,	   trace	   conditioning	  incorporates	   forebrain	  regions	  because	  associating	   the	  CS	  with	   the	  US	  requires	   “bridging	  the	  stimulus	  gap”	  (as	  reviewed	  by	  Woodruff-­‐Pak	  and	  Disterhoft,	  2008).	  	  
	  
Cerebellar	  Cortex,	  Secretin,	  and	  Delay	  Eyeblink	  Conditioning	  	   Secretin	  is	  a	  neuropeptide	  expressed	  in	  the	  somatodentritic	  region	  of	  PCs	  whereas	  secretin	  receptors	  are	  expressed	  on	  BCs,	  PCs,	  and	  neurons	  in	  the	  DCN	  (as	  reviewed	  by	  Yung	  et	  al.,	  2006).	  Purkinje	  cells	  endogenously	  release	  secretin	  when	  they	  become	  depolarized	  (Lee	   et	   al.,	   2005).	   The	   released	   secretin	   acts	   as	   a	   retrograde	   messenger	   that	   binds	   to	  secretin	  receptors	  on	  BCs	  and	  PCs.	  The	  use	  of	  in	  situ	  hybridization	  for	  the	  secretin	  receptor	  mRNA	  found	  that	  the	  secretin	  receptor	  was	  expressed	  in	  both	  PCs	  and	  BCs.	  To	  confirm	  that	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the	   secretin	   receptors	   were	   located	   on	   BCs,	   an	   immunostaining	   technique	   using	  paravalbumin	   antibodies	   was	   conducted.	   Since	   BCs	   are	   GABAergic,	   paravalbumin	  antibodies	   were	   used	   because	   they	  mark	   for	   GABA	   cells.	   It	   was	   found	   that	   there	   was	   a	  coexpression	   of	   paravalbumin	   and	   secretin	   receptor	   in	   the	   molecular	   layer	   of	   the	  cerebellum	   (Yung	   et	   al.	   2001).	   This	   suggests	   that	   secretin	   acts	   on	   secretin	   receptors	   on	  both	  PCs	  and	  BCs.	  	  	  Secretin	   has	   been	   found	   to	   enhance	   delay	   EBC	   when	   infused	   into	   the	   cerebellar	  cortex.	  Williams	  et	  al	  (2012)	  infused	  1.0	  uL	  of	  secretin	  or	  vehicle	  into	  the	  cerebellar	  cortex	  of	  rats	  prior	  to	  the	  first	  three	  sessions	  of	  delay	  EBC.	  	  They	  found	  that	  secretin	  enhanced	  the	  expression	  of	  eyeblink	  CRs	  compared	  to	  vehicle	  infused	  rats.	  One	  possible	  explanation	  for	  this	   enhancement	   is	   that	   secretin	   reduced	   expression	   of	   Kv1.2	   on	   BCs	   (Williams	   et	   al.,	  2012),	  which	  would	   increase	  BC	  release	  of	  GABA	  on	  PCs	  (Southan	  and	  Robertson,	  1998).	  Yung	  et	   al	   (2001)	  utilized	  whole-­‐cell	   patch-­‐clamp	   recording	  of	  PCs	  of	   the	   rat	   cerebellum	  and	   found	   that	   PC	   exposure	   to	   secretin	   increased	   PC	   inhibitory	   postsynaptic	   currents	  (IPSC).	   IPSCs	   indicate	   that	  PCs	  are	  being	   inhibited.	   Inhibition	  of	  PCs	  would	  disinhibit	   the	  IPN	  allowing	  for	  a	  CR	  to	  be	  produced	  once	  the	  animal	  has	  learned	  to	  associate	  the	  CS	  to	  the	  US.	  	  In	  support	  of	  this	  model,	  intra-­‐cerebellar	  infusion	  of	  tityustoxin-­‐Kα	  (TsTx)	  that	  directly	  blocked	  Kv1.2	  function	  in	  cerebellar	  cortex	  also	  enhanced	  acquisition	  in	  EBC	  (Williams	  et	  al.,	  2012).	  In	   a	   study	   by	   Fuchs	   et	   al	   (2014),	   the	   lobulus	   simplex,	   a	   region	   in	   the	   cerebellar	  cortex,	   of	   male	   Wistar	   rats	   was	   pharmacologically	   inhibited	   with	   a	   secretin	   receptor	  antagonist	   (5-­‐27	   secretin).	   Each	   animal	   received	   1.0	   μL	   of	   5-­‐27	   secretin	   or	   1.0	   μL	   of	  phosphate-­‐buffered	  saline	  vehicle	  prior	  to	  the	  first	  three	  training	  sessions	  of	  280-­‐ms	  delay	  EBC.	   There	  was	   an	   impairment	   of	   acquisition	   in	   the	   animals	   that	   received	   5-­‐27	   secretin	  when	  tested	  with	  the	  delay	  EBC	  paradigm	  that	  had	  100	  CS-­‐US	  consecutive	  trials	  per	  session	  (which	   promotes	   strong	   delay	   EBC	   in	   control	   rats).	   These	   findings	   support	   previous	  findings	  by	  Williams	  et	  al	   (2012)	   that	   secretin	   in	   the	   cerebellar	   cortex	  plays	  an	  essential	  role	  in	  acquisition	  of	  eyeblink	  CRs.	  	  The	  present	  experiment	  attempted	  to	  replicate	  the	  findings	  of	  Fuchs	  et	  al	  (2014)	  by	  infusing	   a	   smaller	   volume	   (0.5	   μL)	   of	   5-­‐27	   secretin	   into	   the	   lobulus	   simplex	   near	   the	  primary	  fissure	  prior	  to	  the	  first	  two	  training	  sessions	  of	  delay	  EBC.	  Decreasing	  the	  amount	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of	  5-­‐27	  secretin	   infused	  helped	   to	  determine	   if	   the	   findings	  of	  Fuchs	  et	  al	   (2014)	  were	  a	  result	  of	  5-­‐27	  secretin	  spreading	  to	  the	  IPN	  and	  to	  localize	  secretin	  involvement	  to	  a	  more	  specific	  area	  of	  cerebellar	  cortex.	  	  The	  lobulus	  simplex	  near	  the	  primary	  fissure	  was	  chosen	  as	  the	  site	  of	  infusion	  because	  it	  has	  been	  found	  to	  be	  important	  in	  EBC	  across	  a	  number	  of	  species	  (as	  reviewed	  by	  Freeman	  and	  Steinmetz,	  2011).	  In	  a	  study	  conducted	  by	  Steinmetz	  and	  Freeman	   (2014)	  with	   rats,	   inactivation	  with	  muscimol	  of	   the	   ipsilateral	  hemispheric	  lobule	  VI	  (HVI)(lobulus	  simplex)	  near	  the	  lower	  part	  of	  the	  primary	  fissure	  prior	  to	  delay	  EBC	   impaired	  acquisition.	  Furthermore,	   the	  current	  study	  attempted	   to	  gather	  additional	  evidence	  on	  the	  role	  of	  the	  cerebellum	  in	  trace	  EBC.	  It	  was	  hypothesized	  that	  infusion	  of	  5-­‐27	  secretin	  into	  the	  cerebellar	  cortex	  would	  decrease	  acquisition	  of	  CRs	  in	  both	  delay	  EBC	  and	   trace	   EBC.	   Secretin	   enhances	   delay	   EBC	   when	   infused	   into	   the	   lobulus	   simplex	  (Williams	  el	  al,	  2012)	  whereas	  5-­‐27	  secretin	  impairs	  delay	  EBC	  when	  infused	  into	  the	  same	  region	  of	  the	  cerebellar	  cortex	  (Fuchs	  et	  al,	  2014).	  The	  effects	  of	  5-­‐27	  secretin	  on	  trace	  EBC	  are	  not	  yet	  known.	  Given	  that	  inhibition	  of	  the	  cerebellar	  cortex	  near	  the	  lower	  part	  of	  the	  primary	   fissure	   with	   muscimol	   impairs	   trace	   EBC	   in	   mice	   (Siegel	   et	   al,	   2015)	   and	   rats	  (Steinmetz	  &	  Freeman,	  2014),	  it	  was	  predicted	  that	  5-­‐27	  secretin	  would	  also	  impair	  trace	  EBC.	  	  	  Methods	  The	  basic	  experiment	  was	  a	  2	  x	  2	  factorial	  design:	  Secretin	  receptor	  antagonist	  infusion	  v.	  vehicle	   infusion	   and	   delay	   conditioning	   v.	   trace	   conditioning.	   There	   were	   four	   rats	   per	  cohort	   (tested	   at	   the	   same	   time)	   with	   each	   rat	   representing	   a	   different	   factor	   in	   the	  experiment.	   For	   instance,	   one	   rat	   received	   secretin	   receptor	   antagonist	   and	   delay	  conditioning	  where	   another	   rat	   received	   vehicle	   and	  delay	   conditioning.	   	   There	  were	   14	  cohorts	  of	   4	   rats	   each	   (56	   rats)	   and	  41	  of	   these	   rats	  were	   included	   in	  data	   analysis	   (see	  below).	  	  The	  drug	  was	  administered	  via	  cannula;	  a	  needle-­‐like	  tube	  that	  had	  one	  end	  in	  the	  left	  cerebellar	  cortex	  and	  the	  other	  end	  exposed	  for	  drug	  infusion.	   	  All	  testing	  procedures	  were	   approved	   by	   the	   Institutional	   Animal	   Care	   and	   Use	   Committee	   (IACUC)	   of	   the	  University	  of	  Vermont.	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Surgery	  In	   order	   for	   the	   cannula	   tip	   to	   come	   into	   direct	   contact	   with	   the	   brain,	   each	   rat	   must	  undergo	   surgery.	   	   Surgeries	  were	   done	   under	   aseptic	   conditions.	   	   Rats	  were	   completely	  anesthetized	  with	  3%	  isoflurane	   in	  oxygen.	  Once	  the	  guide	  cannula	  was	   implanted	  (-­‐11.0	  anterior-­‐posterior	  relative	   to	  bregma;	   -­‐3.0	  medial-­‐lateral;	   -­‐3.2	   to	   -­‐3.5	  dorsal-­‐ventral	   from	  the	  skull),	   it	  was	  secured	  to	  the	  skull	  with	  dental	  cement.	   	  A	  bipolar	  electrode	  was	  placed	  subdermally	  near	  the	  corner	  of	  the	  left	  eye	  for	  eye	  stimulation.	  	  The	  bipolar	  electrode	  is	  for	  delivering	  the	  periorbital	  shock.	  	  Two	  electromyography	  (EMG)	  wires	  that	  recorded	  muscle	  movement,	   in	   this	   case	   eye	   blinking,	   were	   placed	   subdermally	   above	   the	   animal’s	   left	  eyelid.	  	  The	  wires	  were	  connected	  to	  a	  pedestal	  connector	  that	  can	  then	  be	  plugged	  into	  a	  tether/commutator	   that	   carries	   wires	   for	   recording	   eye	   blinks	   and	   for	   delivering	   the	  periorbital	  shock.	  	  The	  cannula,	  bipolar	  electrode,	  and	  pedestal	  connector	  were	  secured	  on	  the	  skull	  with	  dental	  cement.	  	  The	  animals	  received	  local	  injections	  of	  0.15	  mL	  bupivacaine	  around	   the	  wound	   as	   soon	   as	   the	   surgeries	   were	   completed.	   	   Subcutaneous	   injection	   of	  saline	   and	   analgesic	   (Carprofen)	   were	   also	   administered	   immediately	   after	   surgery.	  	  Animals	  were	  given	  5-­‐6	  days	  to	  recover	  prior	  to	  eyeblink	  conditioning.	  	  	  	  
Eyeblink	  Conditioning	  Each	  EBC	  session	  consisted	  of	  100	  trials.	  Conditioning	  occurred	  in	  a	  soundproof	  room.	  	  The	  room	  contained	  four	  identical	  chambers	  where	  each	  animal	  was	  individually	  tested.	  	  Each	  chamber	  contained	  a	  speaker	  in	  the	  top	  left	  corner	  where	  the	  tone	  was	  presented.	  	  The	  top	  of	  each	  chamber	  contained	  a	  tether	  and	  the	  pedestal	  connector	  and	  bipolar	  electrode	  of	  the	  animal	  were	  connected	  to	  this	  tether	  prior	  to	  each	  session	  of	  EBC.	   	  The	  tethers	  were	  also	  connected	  to	  the	  laboratory’s	  computer	  system.	  	  Tone	  delivery	  and	  stimulation	  to	  the	  eye	  via	   the	  bipolar	   electrode	  was	   controlled	  by	   a	   computer	   running	  Spike2	   software.	   	   Eyelid	  EMG	  activity	  was	  also	  recorded	  by	  this	  software.	  	  	  	   The	   first	   day	   of	   conditioning	  was	   an	   adaptation	   day.	   	   Rats	  were	   plugged	   into	   the	  tethers	  but	  they	  received	  no	  stimulation.	   	  The	  following	  day	  was	  the	  first	  acquisition	  day.	  Immediately	   prior	   to	   sessions	   1	   and	   2	   of	   acquisition,	   rats	   received	   an	   intracerebellar	  infusion	  via	  the	  cannula	  of	  0.5	  µL	  of	  2.0	  µg/µL	  secretin	  receptor	  antagonist	  (5-­‐27	  secretin)	  or	  vehicle.	  	  This	  was	  done	  by	  inserting	  an	  internal	  cannula	  into	  the	  guide	  cannula,	  with	  the	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internal	   cannula	  protruding	   from	   the	   tip	   of	   the	   guide	   cannula	  by	   approximately	  1.0	  mm.	  	  Infusions	   were	  made	  with	   a	   10	   µl	   Hamilton	   syringe	   loaded	   onto	   an	   infusion	   pump	   (KD	  Scientific,	  Holliston	  MA)	  set	  to	  deliver	  0.5	  µL	  of	  solution	  over	  2	  minutes.	  	  At	  the	  end	  of	  the	  infusion	   period,	   the	   internal	   cannula	   remained	   in	   place	   for	   an	   additional	   1	  min	   to	   allow	  diffusion	  of	   the	   infused	  solution	  away	   from	  the	  cannula	   tip.	   	  As	  soon	  as	   the	   infusion	  was	  completed,	   rats	   were	   placed	   into	   their	   chambers	   and	   underwent	   either	   delay	   or	   trace	  conditioning.	   Each	   session	   consisted	   of	   100	   CS-­‐US	   trials.	   For	   each	   trial	   of	   delay	  conditioning,	   a	   615-­‐ms	   tone	   CS	   co-­‐terminated	   with	   a	   15-­‐ms	   periorbital	   stimulation	   US	  (600-­‐ms	  delay	  EBC).	  	  For	  each	  trial	  of	  trace	  conditioning,	  a	  300-­‐ms	  tone	  CS	  was	  followed	  by	  a	  300-­‐ms	  trace	  period,	  which	  was	  followed	  by	  a	  15-­‐ms	  periorbital	  stimulation	  US	  (600-­‐ms	  trace	   EBC).	   	   Following	   session	   2,	   rats	   underwent	   four	   more	   sessions	   of	   EBC	   (3d	   –	   6d)	  without	  infusions.	  	  	  	  
Data	  Analysis	  The	  raw	  data	  from	  each	  trial	  of	  each	  session	  for	  each	  animal	  was	  analyzed	  using	  MATLAB®.	  Each	  trial	  was	  subdivided	  into	  four	  time	  periods:	  (1)	  a	  “baseline”	  period,	  280-­‐ms	  prior	  to	  CS	  onset;	  (2)	  a	  non-­‐associative	  “startle”	  period,	  0-­‐80	  ms	  after	  CS	  onset;	  (3)	  a	  “CR”	  period,	  81-­‐600	  ms	  after	  CS	  onset;	  and	  (4)	  a	  “UR	  period,”	  65-­‐165	  ms	  after	  US	  onset	  (the	  first	  65	  ms	  is	  obscured	  by	   the	   stimulation	  artifact).	   In	  order	   for	   a	   response	   to	  be	   scored	  as	   a	  CR,	   an	  eyeblink	   had	   to	   exceed	   the	   mean	   baseline	   activity	   for	   that	   trial	   by	   0.5	   arbitrary	   units	  (where	   these	  units	  had	  a	   range	  of	  0.0-­‐5.0)	  during	   the	  CR	  period.	  Eyeblinks	   that	  met	   this	  threshold	   during	   the	   startle	   period	  were	   scored	   as	   startle	   responses	   and	  were	   analyzed	  separately.	  Trials	  in	  which	  eyeblinks	  exceeded	  1.0	  arbitrary	  unit	  during	  the	  baseline	  period	  were	   discarded.	   Comparable	   scoring	   intervals	   and	   criteria	   were	   used	   to	   evaluate	  spontaneous	   blink	   rate	   during	   the	   initial	   adaptation	   day	   when	   no	   stimuli	   were	  administered.	  The	  primary	  dependent	  measure	  for	  all	  experiments	  was	  the	  percentage	  of	  CRs.	   Data	   were	   analyzed	   using	   repeated	   measures	   ANOVAs.	   Separate	   ANOVAs	   were	  conducted	   on	   data	   from	   infusion	   sessions	   (Sessions	   1	   and	   2)	   and	   non-­‐infusion	   sessions	  (Sessions	  3-­‐6).	  We	  computed	  all	  statistical	  analyses	  using	  SPSS	  23.0.	  An	  alpha	  level	  of	  0.05	  was	  set	  as	  the	  rejection	  criterion	  for	  all	  statistical	  tests.	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Figure	   4.	   Sample	   cannula	   placement	   (arrow)	   on	  side	  ipsilateral	  to	  the	  conditioned	  eye.	  
Histology	  Following	  conditioning,	  rats	  were	  euthanized	  with	  sodium	  pentobarbital.	  	  A	  stainless	  steel	  electrode,	   insulated	   except	   for	   its	   tip,	   was	   inserted	   into	   the	   guide	   cannula	   so	   that	   it	  protruded	  from	  the	  cannula	  tip	  by	  about	  1.0	  mm	  (i.e.,	  the	  infusion	  location)	  and	  0.1	  mA	  dc	  current	  was	  passed	  through	  the	  electrode	  for	  approximately	  10	  seconds.	  	  The	  rat	  was	  then	  perfused	   with	   0.9%	   saline	   followed	   by	   10%	   buffered	   formalin.	   Once	   the	   brains	   were	  harvested,	   they	  were	   placed	   in	   10%	  buffered	   formalin.	   	   Around	   five	   days	   prior	   to	   tissue	  analysis,	   the	  brains	  were	   transferred	   to	  a	  30%	  sucrose/	  10%	  buffered	   formalin	   solution.	  	  Then	   brains	  were	   embedded	   in	   albumin	   and	   placed	   in	   a	   freezer.	   A	   cryostat	  was	   used	   to	  section	  the	  cerebellum	  at	  a	  60	  µm	  thickness.	  	  The	  sections	  of	  cerebellum	  were	  then	  placed	  on	  glass	  slides	  and	  stained	  with	  cresyl	  violet	  and	  Prussian	  blue.	  	  Staining	  with	  cresyl	  violet	  was	  used	  to	  visualize	  cell	  bodies	  and	  staining	  with	  Prussian	  blue	  was	  used	  to	  visualize	  the	  electrode-­‐produced	   lesions.	   	   If	   the	   cannula	   could	   not	   be	   located	   then	   the	   data	   from	   that	  animal	  were	  not	  used.	  	  	  Results	  	  	   Prior	  to	  data	  analysis	  the	  cannula	  placement	  for	  each	  animal	  was	  verified	  (Figure	  4).	  Cannula	   placements	   were	   also	   compared	   to	   the	   cannula	   placements	   of	   Steinmetz	   and	  Freeman	   (2014).	   If	   the	   cannula	  placement	   could	   not	   be	   located	   in	  the	  lobulus	  simplex	  of	  the	  cerebellar	  cortex,	  the	  animal	  was	  removed.	  	  The	  first	  day	  of	  training	  consisted	  of	  an	   adaptation	   session	   where	   rats	  were	   placed	   in	   experimental	  chambers	   for	   100	   “trials”	   but	  received	  no	  CS	  or	  US.	  Rats	  were	  then	  trained	   for	   six	   days	   receiving	   100	  CS-­‐US	   paired	   trials	   each	   day	   (600-­‐msec	   delay	   paradigm	   or	   600-­‐msec	  trace	  paradigm).	   Prior	   to	   training	   sessions	  1-­‐2,	   5-­‐27	   secretin	   (0.5	   μL;	   2.0	   μg/μL;	  Ant)	   or	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vehicle	   (0.5	   μL;	   phosphate-­‐buffered	   saline;	   Veh)	   was	   infused	   into	   the	   lobulus	   simplex	  ipsilateral	   to	   the	   conditioned	  eye	  via	   cannula.	  A	   total	  of	  41	  animals	  were	   included	   in	   the	  data	   analysis	   (10	   Delay	   Ant;	   11	   Delay	   Veh;	   10	   Trace	   Ant;	   10	   Trace	   Veh).	   A	   total	   of	   15	  animals	  were	  removed	  due	  to	  poor	  electromyographic	  (EMG)	  signals	  (n=5),	  problems	  with	  bipolar	   placement	   (n=2),	   died	   during	   surgery	   (2),	  euthanized	  due	  to	  upper	  respiratory	  infection	  (n=1),	  or	  not	  able	  to	  locate	  cannula	  placement	  (n=5).	  	  	  
Delay	  Eyeblink	  Conditioning	  	  Both	   the	   Delay	   Vehicle	   and	   Delay	   Antagonist	  groups	   learned	  with	  a	   slight	   trend	   for	  Delay	  Vehicle	   to	  outperform	   Delay	   Antagonist	   though	   there	   was	   no	  statistically	   significant	   difference	   between	   the	   groups	  (Figure	   5A).	   Data	   for	   sessions	   1-­‐2	   was	   analyzed	  separately	   from	   sessions	   3-­‐6	   in	   order	   to	   determine	   if	  infusions	   impaired	   CR	   expression	   without	   impairing	  learning.	  A	  2	  (group:	  Ant;	  Veh)	  by	  2	  (infusion	  sessions:	  1-­‐2)	   repeated-­‐measures	   ANOVA	   on	   the	   percentage	   of	  CRs	   for	   infusion	   days	   yielded	   a	   non-­‐significant	   group	  main	   effect	   (F(1,19)	   =	   0.51,	   p>	   0.05),	   a	   significant	  session	   main	   effect	   (F(1,19)	   =	   20.96,	   p<	   0.05),	   and	   a	  non-­‐significant	   interaction	   effect	   (F(1,19)	   =	   1.22,	   p>	  0.05).	  A	  2	  (group:	  Ant;	  Veh)	  by	  4	  (noninfusion	  sessions:	  3-­‐6)	   repeated	   measures	   ANOVA	   on	   percentage	   of	   CRs	  yielded	   a	   non-­‐significant	   group	   main	   effect	  (F(1,19)	   =	   0.72,	   p>	   0.05),	   a	  significant	   session	   effect	   (F(3,57)	   =	  7.95,	   p<	   0.05)	   and	   a	   non-­‐significant	  interaction	   effect	   (F(3,57)	   =	   0.46,	  p>0.05).	  	  
Figure	  5.	  (A)	  Percentage	  of	  CRs	  over	  adaptation	  and	  sessions	  1-­‐6	  for	  the	  delay	  paradigm	  for	  both	  groups	  (100	  CS-­‐US	  trials	  per	  session).	  Sessions	  1-­‐2	  were	  when	  rats	  received	  infusion	  of	  either	  0.5μL	  of	  5-­‐27	  secretin	  (2.0	  μg/μL)	  or	  0.5μL	  vehicle	  prior	  to	  training.	  (B)	  CR	  amplitude	  for	  sessions	  1-­‐6	  for	  both	  groups.	  (C)	  CR	  onset	  latency	  for	  both	  groups.	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Figure	  6.	  (A)	  Percentage	  of	  CRs	  over	  adaptation	  and	  sessions	  1-­‐6	  for	  the	  trace	  paradigm	  for	  both	  groups	  (100	  CS-­‐US	  trials	  per	  session).	  Sessions	  1-­‐2	  were	  when	  rats	  received	  infusion	  of	  either	  0.5μL	  of	  5-­‐27	  secretin	  (2.0	  μg/μL)	  or	  0.5μL	  vehicle	  prior	  to	  training.	  (B)	  CR	  amplitude	  for	  sessions	  1-­‐6	  for	  both	  groups.	  (C)	  CR	  onset	  latency	  for	  both	  groups.	  	  	  
The	  CR	  amplitude	  measures	  the	  strength	  of	  each	  CR.	  Figure	  5B	  shows	  the	  average	  amplitude	  for	  each	  session.	  It	  is	  independent	  from	  the	  percentage	  of	  CRs	  that	  measures	  CR	  frequency	   over	   the	   100	   trials.	   The	   CR	   onset	   latency	  measures	  the	  time	  it	  takes	  from	  the	  CS	  onset	  to	  when	  the	   rat	   begins	   a	   CR	   and	   is	   shown	   in	   Figure	   5C.	   The	  repeated	  measures	   ANOVA	   for	   CR	   amplitude	   and	   CR	  latency	  for	  sessions	  1-­‐2	  and	  sessions	  3-­‐6	  were	  also	  not	  significant	  (Figures	  5B	  and	  5C).	  	  For	  sessions	  1-­‐2,	  both	  Delay	  Vehicle	  and	  Delay	  Antagonist	  groups	  displayed	  similar	  CR	  amplitude	  (F(1,18)	  =	  0.12,	  p>	  0.05)	  and	  CR	  latencies	   	   F(1,18)	   =	   0.94,	   p>	   0.05).	   The	   same	   was	  found	   for	   sessions	   3-­‐6	  with	   CR	   amplitude	   (F(1,18)	   =	  1.21,	  p>	  0.05)	  and	  CR	  latency	  (F(1,18)	  =	  1.42,	  p<	  0.05).	  	  
	  
Trace	  Eyeblink	  Conditioning	  	  While	   Trace	   Vehicle	   and	   Trace	   Antagonist	   both	  learned,	   there	   was	   a	   trend	   for	   Trace	   Vehicle	   to	  outperform	   Trace	   Antagonist	   by	   sessions	   3-­‐6;	   this	  approached	   but	   did	   not	   attain	   statistical	   significance	  at	  the	  p	  <	  0.05	  level	  (Figure	  6A).	  A	  2	  (group:	  Ant;	  Veh)	  by	   2	   (infusion	   sessions:	   1-­‐2)	   repeated-­‐measures	  ANOVA	   on	   the	   percentage	   of	   CRs	   for	   infusion	   days	  yielded	  a	  non	  significant	  main	  group	  effect	  F(1,18)	  =	  0.48,	   p>0.05),	   a	   significant	   session	  effect	   (F(1,18)	   =	   32.53,	   p<0.05)	   and	  a	   non-­‐significant	   interaction	   effect	  (F(1,18)	  =	  2.17,	  p>	  0.05).	  A	  2	  (group:	  Ant;	   Veh)	   by	   4	   (noninfusion	  sessions:	   3-­‐6)	   repeated	   measures	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Figure	  7.	  (A)	  Percentage	  of	  CRs	  over	  adaptation	  and	  sessions	  1-­‐6	  for	  the	  delay	  vs.	  trace	  paradigm	  for	  both	  vehicle	  groups	  (100	  CS-­‐US	  trials	  per	  session).	  Sessions	  1-­‐2	  were	  when	  rats	  received	  infusion	  of	  0.5μL	  vehicle	  prior	  to	  training.	  (B)	  CR	  amplitude	  for	  sessions	  1-­‐6	  for	  both	  groups.	  (C)	  CR	  onset	  latency	  for	  both	  groups.	  	  	  
ANOVA	   on	   percentage	   of	   CRs	   a	   non-­‐significant	   main	   group	   effect	   (F(1,18)	   =	   3.50,	   p	   =	  0.078),	   a	   significant	   session	   effect	   (F(3,54)	   =	   1.14,	   p<	   0.05)	   and	   a	   non-­‐significant	  interaction	  effect	  (F(3,54)	  =	  1.01,	  p>	  0.05).	  	  	  The	   repeated	   measures	   ANOVA	   for	   CR	  amplitude	   and	   CR	   latency	   for	   sessions	   1-­‐2	   and	  sessions	   3-­‐6	   were	   also	   not	   significant	   (Figures	   6B	  and	   6C).	   	   For	   sessions	   1-­‐2,	   both	   Trace	   Vehicle	   and	  Trace	   Antagonist	   groups	   displayed	   similar	   CR	  amplitude	   (F(1,17)	   =	   0.03,	   p>0.05)	   and	   CR	   latency	  (F(1,18)	  =	  1.28,	  p>	  0.05).	  	  	  
Delay	  vs.	  Trace	  Eyeblink	  Conditioning	  The	   Trace	   Vehicle	   group	   outperformed	   the	   Delay	  Vehicle	   group,	   although	   this	   was	   not	   statistically	  significant	   (Figure	   7A).	   A	   2	   (group:	   Ant;	   Veh)	   by	   2	  (infusion	   sessions:	   1-­‐2)	   repeated-­‐measures	   ANOVA	  on	  the	  percentage	  of	  CRs	  for	  infusion	  days	  yielded	  a	  non	  significant	  main	  group	  effect	  (F(1,19)	  =	  0.05,	  p	  >	  0.05),	  a	  significant	  session	  effect	  (F(1,19)	  =	  33.24,	  p	  <	   0.05),	   and	   a	   non-­‐significant	   group	   x	   session	  interaction	   effect	   (F(1,19)	   =	   0.26,	   p	   >	   0.05).	   	   A	   2	  (group:	   Ant;	   Veh)	   by	   4	   (noninfusion	   sessions:	   3-­‐6)	  repeated-­‐measures	  ANOVA	  on	  the	  percentage	  of	  CRs	  for	   infusion	   days	   yielded	   a	   non	   significant	   group	  main	   effect	   (F(1,19)	   =	   1.92,	   p>0.05),	   a	  significant	   session	   effect	   (F(3,57)	   =	  5.75,	  p	  <	  0.05),	  and	  a	  non-­‐significant	  group	   x	   session	   interaction	   effect	  (F(3,57)	   =	   1.29,	   p	   >0.05).	   	   Similar	  results	   were	   found	   for	   comparisons	  of	  CR	  amplitude	  and	  CR	  onset	  latency.	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Discussion	  
Summary	  of	  Results	  	  The	  effect	  of	  5-­‐27	  secretin	  infusions	  into	  cerebellar	  cortex	  on	  both	  delay	  and	  trace	  EBC	  was	  studied	  in	  the	  present	  experiment.	  Given	  the	  results	  of	  Fuchs	  et	  al	  (2014),	  this	  study	  was	  aimed	  at	  determining	  if	  a	  smaller	  volume	  of	  5-­‐27	  secretin	  could	  replicate	  an	  impairment	  in	  delay	  EBC.	  Instead	  of	  1µL	  only	  0.5	  µL	  of	  5-­‐27	  secretin	  was	  administered	  over	  the	  course	  of	  two	  infusion	  days	  instead	  of	  three.	  This	  experiment	  also	  sought	  to	  better	  understand	  the	  role	  of	  the	  cerebellum	  in	  trace	  EBC	  because	  there	  is	  disagreement	  in	  the	  literature	  regarding	  whether	  or	  not	  trace	  EBC	  requires	  cerebellar	  cortex.	  	  While	  no	  statistically	  significant	  difference	  was	  found,	  there	  was	  a	  trend	  for	  the	  Delay	  Antagonist	  group	  and	  Trace	  Antagonist	  group	  to	  underperform	  in	  comparison	  to	  their	  respective	  control	  groups.	  This	  was	  particularly	  true	  for	  the	  Trace	  Antagonist	  group	  over	  non-­‐infusion	  sessions	  3-­‐6	  (Figure	  6A).	  Finally,	  the	  Trace	  Vehicle	  group	  slightly	  outperformed	  the	  Delay	  Vehicle	  group	  (Figure	  7).	  It	  was	  predicted	  that	  the	  Delay	  Vehicle	  group	  would	  outperform	  the	  Trace	  Vehicle	  or	  that	  at	  least	  the	  groups	  would	  perform	  the	  same.	  	  	  	  
	  Effects	  of	  5-­‐27	  Secretin	  on	  Delay	  Eyeblink	  Conditioning	  	  Acquisition	  of	  CRs	  during	  delay	  EBC	  has	  been	  found	  to	  be	  a	  cerebellar	  dependent	  process	  by	  many	  studies;	  however,	  the	  methods	  used	  by	  these	  studies	  differ.	  For	  example,	  Garcia	  et	  al.	  (1999)	  inactivated	  the	  anterior	  lobe	  of	  the	  cerebellar	  cortex	  of	  rabbits	  via	  aspiration	  lesions	  and	  electrolytic	  lesions	  after	  subjects	  had	  been	  trained	  to	  asymptotic	  performance	  in	  a	  500-­‐ms	  delay	  paradigm.	  It	  was	  found	  that	  the	  timing	  of	  CRs	  was	  disrupted	  and	  that	  the	  acquisition	  of	  CRs	  to	  a	  new	  CS	  was	  abolished.	  These	  results	  suggest	  that	  the	  cerebellar	  cortex	  is	  required	  for	  both	  retention	  of	  a	  previously	  established	  CR	  as	  well	  as	  for	  acquisition	  of	  a	  new	  CR.	  In	  addition,	  Woodruff-­‐Pak	  et	  al,	  (2006)	  used	  pcd	  mutant	  mice	  lacking	  Purkinje	  cells	  and	  found	  that	  delay	  EBC	  was	  impaired.	  	  It	  is	  important	  to	  note	  that	  the	  only	  experiment	  that	  has	  used	  5-­‐27	  secretin	  to	  study	  the	  role	  of	  the	  cerebellum	  in	  rat	  delay	  EBC	  is	  the	  Fuchs	  et	  al.	  (2014)	  study.	  Thus	  it	  is	  possible	  that	  the	  type	  of	  delay	  paradigm	  used,	  the	  change	  of	  infusion	  procedures,	  and	  the	  type	  of	  species	  used	  prevented	  significant	  results	  from	  being	  found	  in	  the	  current	  experiment.	  The	  findings	  for	  the	  delay	  EBC	  group	  were	  different	  from	  our	  previous	  study	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(Fuchs	  et	  al.	  2014).	  	  Specifically,	  there	  was	  no	  difference	  in	  performance	  between	  the	  Delay	  Vehicle	  and	  the	  Delay	  Antagonist	  groups	  with	  both	  groups	  displaying	  an	  equal	  percentage	  of	  CRs,	  CR	  amplitude,	  and	  CR	  onset	  latency	  across	  all	  six	  sessions.	  One	  plausible	  explanation	  for	  this	  is	  that	  the	  volume	  of	  5-­‐27	  secretin	  infused	  into	  the	  lobulus	  simplex	  was	  not	  sufficient	  to	  produce	  an	  impairment	  in	  learning.	  Fuchs	  et	  al.	  (2014)	  infused	  1	  μL	  (1	  µg/	  µL)	  of	  5-­‐27	  secretin	  before	  training	  sessions	  1-­‐3	  and	  found	  that	  delay	  EBC	  was	  impaired	  in	  the	  experimental	  group	  in	  post-­‐infusion	  sessions	  4-­‐6.	  The	  present	  study	  infused	  0.5	  μL	  (2	  µg/	  µL)	  of	  5-­‐27	  secretin	  before	  training	  sessions	  1-­‐2.	  It	  is	  possible	  that	  this	  change	  in	  infusion	  procedure	  may	  have	  reduced	  the	  effects	  of	  5-­‐27	  secretin	  on	  cerebellar	  learning.	  The	  cannula	  placement	  in	  the	  present	  study	  was	  slightly	  more	  anterior	  and	  lateral	  than	  Fuchs	  et	  al	  (2014)	  (11.3	  mm	  posterior	  to	  bregma	  and	  2.5	  mm	  lateral	  to	  the	  midline	  in	  Fuchs	  et	  al.	  compared	  to	  11.0	  mm	  posterior	  to	  bregma	  and	  3.0	  mm	  lateral	  to	  the	  midline)	  in	  order	  to	  match	  the	  coordinates	  of	  Steinmetz	  and	  Freeman	  (2014),	  who	  found	  this	  to	  be	  the	  most	  effective	  location	  for	  inactivation-­‐induced	  deficits	  in	  EBC.	  This	  change	  in	  infusion	  location	  may	  also	  have	  contributed	  to	  the	  difference	  in	  results.	  In	  addition,	  Fuchs	  et	  al.	  (2014)	  utilized	  a	  delay	  paradigm	  where	  the	  tone	  CS	  lasted	  295-­‐ms	  and	  co-­‐terminated	  with	  a15-­‐ms	  periorbital	  stimulation	  as	  the	  US.	  The	  present	  study	  used	  a	  tone	  CS	  that	  lasted	  615-­‐ms	  that	  co-­‐terminated	  with	  a	  15-­‐ms	  periorbital	  stimulation	  as	  the	  US.	  It	  is	  possible	  that	  the	  295-­‐ms	  paradigm	  allowed	  the	  Delay	  Vehicle	  group	  to	  learn	  more	  efficiently	  than	  the	  600-­‐ms	  paradigm.	  If	  so,	  the	  difference	  between	  the	  Delay	  Vehicle	  and	  Delay	  Antagonist	  groups	  in	  Fuchs	  et	  al.	  (2014)	  could	  have	  been	  made	  more	  pronounced.	  Furthermore,	  while	  Fuchs	  et	  al.	  (2014)	  found	  an	  impairment	  in	  learning	  with	  intra-­‐cerebellar	  5-­‐27	  secretin	  during	  the	  100	  CS-­‐US	  per	  session	  delay	  paradigm,	  they	  found	  no	  difference	  between	  Delay	  Vehicle	  and	  Delay	  Antagonist	  groups	  when	  utilizing	  a	  delay	  paradigm	  consisting	  of	  80	  CS-­‐US	  per	  session	  interspersed	  with	  CS	  or	  US	  probes.	  It	  was	  suggested	  that	  the	  since	  the	  Delay	  Vehicle	  group	  learned	  more	  slowly	  in	  the	  80	  CS-­‐US	  per	  session	  interspersed	  with	  CS	  or	  US	  probes	  paradigm	  compared	  to	  the	  Delay	  Vehicle	  100	  CS-­‐US	  paradigm,	  the	  effects	  of	  5-­‐27	  secretin	  on	  the	  Delay	  Antagonist	  group	  may	  have	  been	  more	  difficult	  to	  observe.	  These	  differences	  in	  results	  suggest	  that	  the	  effects	  of	  5-­‐27	  secretin	  may	  only	  be	  revealed	  when	  EBC	  is	  strong	  in	  the	  control	  group.	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Effects	  of	  5-­‐27	  Secretin	  on	  Trace	  Eyeblink	  Conditioning	  	  Interestingly,	  in	  the	  trace	  EBC	  groups,	  the	  Trace	  Antagonist	  group	  showed	  a	  noticeable	  reduction	  in	  percent	  CRs	  compared	  to	  the	  Trace	  Vehicle	  group,	  unlike	  the	  Delay	  Antagonist	  group	  compared	  to	  the	  Delay	  Vehicle	  group.	  The	  difference	  between	  the	  Trace	  Antagonist	  and	  Trace	  Vehicle	  groups	  approached	  statistical	  significance	  in	  post-­‐infusion	  sessions	  3-­‐6	  (p	  =	  0.078).	  The	  current	  findings	  suggest	  that	  trace	  EBC	  does	  require	  the	  cerebellar	  cortex.	  This	  would	  agree	  with	  the	  findings	  of	  Woodruff-­‐Pak	  et	  al.	  (1985),	  Kalmbach	  et	  al	  (2009),	  and	  Siegel	  et	  al.	  (2015).	  	  However,	  it	  is	  important	  to	  note	  that	  while	  secretin	  in	  the	  cerebellar	  cortex	  has	  been	  shown	  to	  play	  a	  role	  in	  delay	  EBC	  (Fuchs	  et	  al.,	  2014;	  Williams	  et	  al.,	  2012),	  nothing	  is	  known	  about	  a	  possible	  role	  in	  trace	  EBC.	  Given	  our	  findings,	  it	  is	  possible	  that	  secretin	  plays	  a	  greater	  role	  in	  trace	  EBC.	  Secretin	  is	  endogenously	  released	  by	  PCs	  upon	  depolarization	  (Lee	  et	  al.	  2005)	  and	  has	  been	  found	  to	  enhance	  cerebellar	  learning	  (Williams	  et	  al.	  2012).	  The	  mechanism	  by	  which	  cerebellar	  cortical	  secretin	  facilitates	  EBC	  is	  not	  fully	  understood.	  One	  view	  is	  that	  secretin	  decreases	  the	  expression	  of	  the	  potassium	  channel	  subunit	  Kv1.2	  at	  BC-­‐PC	  synapses	  (Williams	  et	  al.	  2012)	  that	  in	  turn	  increases	  the	  release	  of	  GABA	  from	  BCs	  onto	  PCs	  (Southan	  and	  Robertson,	  1998).	  	  This	  in	  turn	  allows	  for	  the	  disinhibition	  of	  the	  IPN	  resulting	  in	  a	  CR.	  It	  is	  possible	  that	  secretin	  in	  the	  cerebellum	  plays	  a	  similar	  role	  in	  trace	  EBC	  as	  it	  does	  in	  delay	  EBC.	  This	  would	  support	  the	  finding	  that	  the	  Trace	  Antagonist	  group	  was	  impaired	  compared	  to	  the	  Trace	  Vehicle	  group.	  The	  reason	  why	  the	  Delay	  Antagonist	  did	  not	  display	  as	  great	  an	  impairment	  may	  have	  been	  because	  of	  the	  type	  of	  delay	  paradigm	  used	  as	  described	  in	  the	  previous	  section.	  	  
	  
Comparison	  of	  Delay	  and	  Trace	  Paradigms	  	  The	  difference	  in	  acquisition	  between	  the	  Delay	  Vehicle	  and	  the	  Trace	  Vehicle,	  although	  relatively	  small,	  was	  not	  expected.	  If	  anything,	  the	  Delay	  Vehicle	  group	  should	  have	  displayed	  a	  greater	  percentage	  of	  CRs	  than	  the	  Trace	  Vehicle	  group	  because	  delay	  EBC	  utilizes	  a	  simpler	  circuit	  compared	  to	  trace	  EBC	  (as	  reviewed	  by	  Woodruff-­‐Pak	  and	  Disterhoft,	  2008).	  	  One	  possible	  explanation	  for	  the	  slower	  learning	  of	  delay	  EBC	  compared	  to	  trace	  EBC	  that	  we	  observed	  is	  that	  the	  trace	  paradigm	  used	  required	  minimal	  forebrain	  activity	  and	  thus	  resembled	  the	  neural	  circuitry	  of	  delay	  EBC.	  This	  idea	  is	  supported	  by	  a	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Concluding	  Remarks	  	  	  While	  the	  results	  of	  this	  study	  are	  inconclusive,	  they	  do	  suggest	  that	  trace	  EBC	  requires	  the	  cerebellar	  cortex,	  in	  addition	  to	  the	  IPN.	  It	  is	  possible	  that	  the	  subject	  size	  for	  each	  group	  was	  too	  small	  to	  reveal	  a	  significant	  difference	  between	  the	  groups.	  Increasing	  the	  number	  of	  animals	  in	  each	  group	  while	  using	  the	  same	  methods	  may	  help	  attain	  more	  conclusive	  results.	  Furthermore,	  the	  effects	  of	  intra-­‐cerebellar	  5-­‐27	  secretin	  on	  delay	  EBC	  may	  have	  been	  prevented	  from	  becoming	  significant	  because	  of	  a	  slow	  learning	  Delay	  Vehicle	  group.	  This	  is	  a	  possibility	  given	  that	  the	  first	  experiment	  in	  Fuchs	  et	  al.	  (2014)	  did	  not	  reveal	  a	  significant	  difference	  between	  the	  Delay	  Vehicle	  and	  Delay	  Antagonist	  groups	  because	  of	  the	  slow	  learning	  Delay	  Vehicle	  group.	  This	  is	  also	  supported	  by	  the	  differences	  between	  the	  Delay	  Vehicle	  and	  Trace	  Vehicle	  groups	  in	  the	  current	  study.	  While	  it	  was	  expected	  that	  the	  Delay	  Vehicle	  group	  would	  acquire	  CRs	  at	  the	  same	  rate	  or	  more	  quickly	  than	  the	  Trace	  Vehicle	  group,	  this	  was	  not	  the	  case.	  The	  slow	  learning	  Delay	  Vehicle	  group	  may	  have	  reduced	  detection	  of	  the	  effects	  that	  5-­‐27	  secretin	  had	  on	  the	  Delay	  Antagonist	  group.	  	  Also	  important	  is	  the	  cannula	  placement	  in	  the	  cerebellar	  cortex.	  While	  cannula	  placements	  were	  located	  using	  a	  microscope,	  a	  more	  in-­‐depth	  analysis	  would	  be	  required	  to	  determine	  whether	  the	  exact	  location	  of	  the	  cannula	  tip	  was	  related	  to	  performance.	  Differences	  in	  cannula	  tip	  location	  may	  have	  had	  an	  impact	  on	  how	  drug	  infusion	  affected	  conditioning.	  Steinmetz	  and	  Freeman	  (2014)	  found	  that	  acquisition	  of	  CRs	  was	  severely	  impaired	  in	  rats	  that	  received	  infusion	  of	  muscimol	  prior	  to	  EBC	  via	  cannula	  tips	  located	  in	  the	  eyeblink	  conditioning	  microzone	  (EMC)	  in	  the	  anterior	  lobe	  or	  lobulus	  simplex	  of	  the	  cerebellar	  cortex.	  Rats	  that	  had	  cannula	  tip	  placements	  located	  outside	  of	  the	  EMC	  (usually	  a	  bit	  more	  dorsal)	  did	  not	  display	  as	  great	  of	  an	  impairment.	  The	  EMC	  consists	  of	  a	  specific	  group	  of	  PCs	  that	  are	  believed	  to	  play	  a	  direct	  role	  in	  CR	  acquisition.	  Given	  these	  results,	  the	  present	  study	  could	  analyze	  cannula	  placements	  in	  greater	  detail	  to	  determine	  their	  location	  relative	  to	  the	  EMC.	  	  	   Future	  work	  should	  focus	  on	  understanding	  the	  role	  of	  cerebellar	  secretin	  in	  trace	  EBC.	  An	  experimental	  procedure	  similar	  to	  that	  of	  Williams	  et	  al.	  (2012)	  could	  be	  conducted	  to	  analyze	  how	  secretin	  modulates	  trace	  EBC.	  This	  would	  add	  to	  our	  knowledge	  of	  how	  the	  cerebellum	  treats	  trace	  EBC	  and	  how	  it	  compares	  to	  delay	  EBC.	  	  Another	  experiment	  could	  be	  set	  up	  to	  analyze	  how	  different	  paradigms	  affect	  both	  delay	  and	  trace	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EBC.	  For	  instance,	  delay	  conditioning	  could	  be	  analyzed	  with	  295-­‐ms,	  400-­‐ms,	  and	  600-­‐ms	  delay	  paradigms	  to	  determine	  if	  the	  rate	  of	  acquisition	  varies.	  Trace	  conditioning	  could	  be	  tested	  under	  600-­‐ms	  (300-­‐ms	  tone	  followed	  by	  300-­‐ms	  interval),	  700-­‐ms	  (350-­‐ms	  tone	  followed	  by	  350-­‐ms	  interval),	  and	  800-­‐ms	  (400-­‐ms	  tone	  followed	  by	  400-­‐ms	  interval)	  trace	  paradigms	  to	  determine	  if	  the	  idea	  postulated	  by	  Raybuck	  and	  Lattal	  (2014)	  on	  the	  mechanism	  of	  trace	  conditioning	  is	  supported	  or	  not.	  These	  types	  of	  studies	  will	  help	  further	  elucidate	  the	  role	  the	  cerebellum	  has	  in	  trace	  EBC.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
EFFECTS	  OF	  SECRETIN	  RECEPTOR	  ANTAGONIST	  ON	  EBC	  	  
	   21	  
References	  	  Brown,	   K.,	   Agelan,	   A.,	   Woodruff-­‐Pak,	   D.	   (2009).	   	   Unimpaired	   trace	   classical	   eyeblink	  conditioning	   in	   purkinje	   cell	   degeneration	   (pcd)	   mutant	   mice.	   Neurobiology	   of	  
Learning	  and	  Memory,	  93,	  303-­‐311.	  	  	  Christian,	  K.	  Thompson,	  R.	  (2003).	  Neural	  substrates	  of	  eyeblink	  conditioning:	  acquisition	  and	  retention.	  Cold	  Spring	  Harbor	  Laboratory	  Press,	  11,	  427-­‐455	  Freeman,	   J.,	   Steinmetz,	   A.	   (2011).	   Neural	   circuitry	   and	   plasticity	  mechanisms	   underlying	  delay	  eyeblink	  conditioning.	  Cold	  Spring	  Harbor	  Laboratory	  Press,	  18,	  666-­‐677.	  	  Fuchs,	   J.,	   Robinson,	   G.,	   Dean,	   A.,	   Schoenberg,	   Williams,	   M.,	   Morielli,	   A.,	   Green,	   J.	   (2014).	  Cerebellar	   secretin	  modulates	   eyeblink	   classical	   conditioning.	   	  Cold	  Spring	  Harbor	  
Laboratory	  Press,	  21,	  668-­‐675.	  	  Garcia,	   K.,	   Mauk,	   M.	   (1998).	   Pharmacological	   analysis	   of	   cerebellar	   contribution	   to	   the	  timing	   and	   expression	   of	   conditioned	   eyelid	   responses.	   Neuropharmacology,	   37,	  471-­‐80.	  	  Garcia,	   K.,	   Steele,	   P.,	   Mauk,	   M.	   (1999).	   Cerebellar	   cortex	   lesions	   prevent	   acquisition	   of	  conditioned	  eyelid	  responses.	  The	  Journal	  of	  Neuroscience,	  19(24),	  10940-­‐47.	  Green,	  J.,	  &	  Arenos,	  J.	  (2007).	  Hippocampal	  and	  cerebellar	  single-­‐unit	  activity	  during	  delay	  and	   trace	   eyeblink	   conditioning	   in	   the	   rat.	   	  Neurobiology	  of	  Learning	  and	  Memory,	  
87,	  269-­‐284.	  Kalmbach,	   B.,	   Ohyama,	   T.,	   Kreider,	   J.,	   Riusech,	   F.,	  Mauk,	  M.	   (2009).	   Interactions	   between	  prefrontal	  cortex	  and	  cerebellum	  revealed	  by	  trace	  eyelid	  conditioning.	  Cold	  Spring	  
Harbor	  Laboratory	  Press,	  16,	  86-­‐95.	  Kalmbach,	   B.,	   Ohyama,	   T.,	   Mauk,	  M.	   (2010).	   	   Temporal	   patterns	   of	   inputs	   to	   cerebellum	  necessary	   and	   sufficient	   for	   trace	   eyelid	   conditioning.	   	   Journal	  of	  Neurophysiology,	  
104(2),	  627-­‐640.	  	  	  	  	  Lee,	   S.,	   Chen,	   L.,	   Chow,	   B.,	   Yung,	  W.	   (2005).	   Endogenous	   release	   and	  multiple	   actions	   of	  secretin	  in	  the	  rat	  cerebellum.	  Neuroscience,	  134(2),	  377-­‐386.	  Mauk,	  M.,	  Steinmetz,	  J.,	  Thompson,	  R.	  (1986).	  Classical	  conditioning	  using	  stimulation	  of	  the	  inferior	   olive	   as	   the	   unconditioned	   stimulus.	   	  The	   Journal	  of	  Neuroscience,	  83(14),	  5349-­‐5353.	  	  	  Purves,	  D.	  Augustine,	  G.	   J.,	  Fitzpatrick,	  D.	  Hall,	  W.	  C.,	  LaMantia,	  A-­‐S.,	  &	  White,	  L.	  E.	  (2012).	  
Neuroscience	  (5th	  edition).	  Sunderland,	  MA:	  Sinauer.	  Rasmussen,	   A.,	   Jirenhed,	   D.,	  Wetmore,	   D.,	   Hesslow,	   G.	   (2014).	   Changes	   in	   complex	   spike	  activity	  during	  classical	  conditioning.	  Front	  Neural	  Circuits,	  8.	  	  Raybuck,	   J.,	   &	   Lattal	   K.	   (2014).	   Bridging	   the	   interval:	   theory	   and	   neurobiology	   of	   trave	  conditioning.	  Behavioral	  Processes,	  101,	  103-­‐11.	  Siegel,	   J.,	   Mauk,	   M.	   (2013).	   Persistent	   activity	   in	   prefrontal	   cortex	   during	   trace	   eyeblink	  conditioning:	  dissociated	  responses	  the	  reflect	  cerebellar	  output	  from	  those	  that	  do	  not/	  The	  Journal	  of	  Neuroscience,	  33(38),	  15272-­‐284.	  
EFFECTS	  OF	  SECRETIN	  RECEPTOR	  ANTAGONIST	  ON	  EBC	  	  
	   22	  
Siegel,	  J.,	  Taylor,	  W.,	  Gray,	  R.,	  Kalmbach,	  B.,	  Zemelman,	  B.,	  Desai,	  N.,	  Johnston,	  D.,	  Chitwood,	  R.	  (2015).	  Trace	  eyeblink	  conditioning	  in	  mice	  is	  dependent	  upon	  the	  dorsal	  medial	  prefrontal	   cortex,	   cerebellum,	   and	   amygdala:	   behavioral	   characterization	   and	  functional	  circuitry.	  ENeuro,	  2(4),	  1-­‐29.	  	  Solomon,	   P.,	   Vander	   Schaaf,	   E.,	   Thompson,	   R.,	  Weisz,	   D.	   (1986).	   Hippocampus	   and	   trace	  conditioning	  of	   the	  rabbit’s	  classically	  conditioned	  nictitating	  membrane	  response.	  
Behavioral	  Neuroscience,	  100(5),	  729-­‐744.	  Southan,	  A.,	  Roberton,	  B.	  (1998).	  Modulation	  of	  inhibitory	  post-­‐synaptic	  currents	  (IPSCs)	  in	  mouse	  cerebellar	  purkinje	  and	  basket	  cells	  by	  snake	  and	  scorpion	  toxin	  K+	  channel	  blockers.	  Journal	  of	  Pharmacology,	  124,	  1375-­‐81.	  	  Steinmetz,	  A.	  &	  Freeman,	   J.	   (2014).	  Localization	  of	   the	  cerebellar	   cortical	   zone	  mediating	  acquisition	  of	   eyeblink	   conditioning	   in	   rats.	  Neurobiology	  of	  Learning	  and	  Memory,	  
114,	  148-­‐54.	  	  Takehara,	  K.,	  Kawahara,	  S.,	  Kirino,	  Y.	   (2003).	  Time-­‐dependent	  reorganization	  of	   the	  brain	  components	  underlying	  memory	  retention	  in	  trace	  eyeblink	  conditioning.	  Journal	  of	  
Neuroscience,	  23(30),	  9897-­‐05.	  Tseng,	   W.,	   Guan,	   R.,	   Disterhoft,	   J.,	   Weiss,	   C.	   (2004).	   Trace	   eyeblink	   conditioning	   is	  hippocampal	  dependent	  in	  mice.	  Hippocampus,	  14,	  58-­‐65.	  	  Voogd,	   J.,	   Glickstein,	  M.	   (1998).	   The	   anatomy	   of	   the	   cerebellum.	  Trends	   in	  Neurosciences,	  
21(9),	  370-­‐375.	  Weiss,	   C.,	   Bouwmeester,	   H.,	   Power,	   J.,	   Disterhoft,	   J.	   (1999).	   Hippocampal	   lesions	   prevent	  trace	  eyeblink	  conditioning	  in	  the	  freely	  moving	  rat.	  Behavioral	  Brain	  Research,	  99,	  123-­‐132.	  Williams,	  M.,	   Fuchs,	   J.,	  Green,	   J.,	  Morielli,	  A.	   (2012).	   	   Cellular	  Mechanisms	  and	  Behavioral	  Consequences	   of	   Kv1.2	   Regulation	   in	   the	   Rat	   Cerebellum.	   The	   Journal	   or	  
Neuroscience,	  32(27),	  9228-­‐9237.	  	  	  Woodruff-­‐Pak,	  D.,	  Disterhoft,	  J.	  (2008).	  	  Where	  is	  the	  trace	  in	  trace	  conditioning?	  Cell	  Press,	  
31(2),	  105-­‐112.	  	  	  Woodruff-­‐Pak,	   D.,	   Green,	   J.,	   Levin,	   S.,	   Meisler,	   M.	   (2006).	   Inactivation	   of	   sodium	   channel	  Scn8A	   (Nav1.6)	   in	   purkinje	   neurons	   impairs	   learning	   in	   Morris	   Water	   Maze	   and	  delay	  but	  not	  trace	  eyeblink	  classical	  conditioning.	  Behavioral	  Neuroscience,	  120(2),	  229-­‐40.	  Woodruff-­‐Pak,	   D.,	   Lavond,	   D.,	   Thompson,	   R.	   (1985).	   Trace	   conditioning:	   abolished	   by	  cerebellar	   nuclear	   lesions	   but	   not	   lateral	   cerebellar	   cortex	   apspirations.	   Brain	  
Research,	  348(2),	  249-­‐260.	  Yung,	  W.,	   Leung,	   P.,	   Ng,S.,	   Zhang,	   J.,	   Chan,	   S.,	   Chow,	   B.	   (2001).	   	   Secretin	   facilitates	   GABA	  transmission	  in	  the	  cerebellum.	  	  Journal	  of	  Neuroscience,	  21(18),	  7063-­‐7068.	  	  	  Yung,	  W.,	   Chan,	  Y.,	   Chow,	  B.,	  Wang,	   J.	   (2006).	  The	   role	  of	   secretin	   in	   the	   cerebellum.	  The	  
Cerebellum,	  5(1),	  43-­‐48.	  	  
